AUDITED(STANDALONE AND CONSOLIDATED) FINANCIAL RESULTS FOR THE QUARTER AND FINANCIAL YEAR ENDED MARCH 31, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Titan Securities Ltd reported audited results for FY25 with standalone revenue from operations rising to ₹967.14 lakhs from ₹634.12 lakhs in FY24, a growth of roughly 52%. Standalone profit after tax stood at ₹113.25 lakhs (FY24: ₹107.39 lakhs), up about 5%, while Q4FY25 remained in the red at a loss of ₹10.88 lakhs. On a consolidated basis, including its share of profits from associates Titan Biotech and Peptech Biosciences (₹934.11 lakhs), net profit rose to ₹1,047.36 lakhs from ₹1,006.93 lakhs. The statutory auditor, A N S K & Associates, issued an unmodified (clean) opinion on both standalone and consolidated results, and the company separately filed a declaration confirming the same.
Clean audit report and strong consolidated earnings driven by associate companies are positive signals for shareholders, though the standalone core business remains small and Q4 standalone slipped to a loss. Investors should note that consolidated profit depends heavily on associate performance, and cash balances dropped sharply from ₹135.78 lakhs to ₹11.75 lakhs due to investment purchases.